A 10-year study of 5,275 men with the early stages of disease, conducted by the Texas Southwestern Medical School in Dallas, US, found that aspirin reduced the risk of dying from 10 per cent to four per cent. They discovered that patients with tumours which had not spread beyond the prostate gland, and who were also being treated with surgery or radiation, saw a drastic improvement in their life expectancy by taking the drug.
And earlier this year, US researchers said the painkiller could help women with breast cancer. Of the 5,275 men taking part in the study, 1,982 were taking anticoagulant drugs such as aspirin and warfarin - usually for other conditions such as heart disease. As a result there were varying doses of anticoagulants being taken. The anti-cancer effect was found with all such drugs but was "most prominent" with aspirin. The risk of prostate cancer spreading to the bones was also cut, along with the risk of dying from the disease. IANS
Cut carbohydrate intake, live longer
Scientists unveil new method to create bioartificial organs